Statistics for Navamedic ASA (id:10464 NAVA)
Valuation metrics
Market cap
420.37M
Enterprise value
491.72M
Trailing P/E (ttm)
17.00
Forward P/E
14.08
PEG ratio
14.08
Price/Sales (ttm)
0.80
Price/Book (mrq)
1.86
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
8.90
Overview
Shares outstanding
17.66M
Float
11.87M
Shares short
% Held by insiders
0.44%
% Held by institutions
0.25%
Average volume (10 days)
14.06K
Average volume (90 days)
Price summary
52-Week low
23.00
52-Week high
40.00
52-Week change
-44.02%
Beta
0.43
50-Day moving average
28.84
200-Day moving average
32.61
Dividends and splits
Forward annual dividend rate
3.99
Forward annual dividend yield
0.15
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
April 13th, 2010
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
3.73%
Operating margin
3.87%
Operational effectiveness
Return on assets
5.20%
Return on equity
8.14%
Income statement
Revenue (ttm)
29.64
Revenue per share (ttm)
29.64
Quarterly revenue growth (yoy)
-0.71
Gross profit (ttm)
199.05M
EBITDA
55.29M
Net income to common (ttm)
19.62M
Diluted EPS (ttm)
1.40
Quarterly earnings growth (yoy)
-70.80%
Balance sheet
Total cash (mrq)
46.47M
Total cash per share (mrq)
2.68
Total debt (mrq)
126.92M
Total Debt/Equity (mrq)
48.05
Current ratio (mrq)
163.80%
Book value per share (mrq)
12.82
Cash flow
Cash flow statement
9.27M
Levered free cash flow (LFCF)
22.96M